| Filed On | Filing |
|---|---|
| 03 Jun 2026 | Form 3: McAdory John Bearden, Chief Operating Officer |
| 03 Jun 2026 |
Form 3: Glover Stephen C., Director
No securities owned |
| 02 Jan 2026 |
Form 3: Andrews Patricia S, Director
Holds 42,728 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Look Kirk, Chief Financial Officer
Holds 275,515 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Kelly Jared, Director
Holds 73,900 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Hagerman Allison, VP, Product Development
Holds 105,059 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Heineman Thomas Charles, Chief Medical Officer
Holds 270,686 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Holtham Angela, Director
Holds 178,326 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Parsons James T., Director
Holds 31,849 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Seizinger Bernd R., Director
Holds 366,991 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Pisano Wayne, Director
Holds 462,414 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Brown Deborah Margaret, Director
Holds 84,851 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Aromando Andrew, Chief Business Officer
Holds 25,500 shares of Common Shares |
| 02 Jan 2026 |
Form 3: Rigby Jonathan, Director
Holds 42,728 shares of Common Shares |
Loading...